Martin Pul News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Autolus Therapeutics (AUTL) Receives a Buy from Needham

Needham analyst Gil Blum reiterated a Buy rating on Autolus Therapeutics (AUTL – Research Report) today and set a price target of $7.00. T.

City ofUnited kingdomGil blumSelecta biosciencesAutolus therapeutics plcAutolus therapeuticsResearch reportNurix therapeuticsStrong buyMizuho securitiesAutolus therapeuticTherapeutics plcMultiple myelomaMartin pul

Mizuho Securities Keeps Their Buy Rating on Autolus Therapeutics (AUTL)

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Autolus Therapeutics (AUTL - Research Report) today and set a price target of .

United kingdomCity ofMara goldsteinAutolus therapeutics plcMerck companyMizuho securitiesAutolus therapeuticsArcus biosciencesStrong buyTherapeutics plcMultiple myelomaMartin pul

Mizuho Securities Thinks Autolus Therapeutics Stock is Going to Recover

Mizuho Securities Thinks Autolus Therapeutics Stock is Going to Recover
markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofMara goldsteinIovance biotherapeuticsAutolus therapeutics plcMizuho securitiesAutolus therapeuticsResearch reportAdaptimmune therapeuticsStrong buyTherapeutics plcMultiple myelomaMartin pul

Autolus Therapeutics (AUTL) Receives a Buy from Needham

Autolus Therapeutics (AUTL) Receives a Buy from Needham
markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofGil blumAutolus therapeutics plcRocket pharmaceuticalsAutolus therapeuticsResearch reportCrispr therapeuticsTaysha geneStrong buyMizuho securitiesTherapeutics plcMultiple myelomaMartin pul

Autolus Therapeutics : and Moderna sign Option and License Agreement for access to proprietary targeting technology from

Autolus Therapeutics : and Moderna sign Option and License Agreement for access to proprietary targeting technology from
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSusana noonanJulia wilsonLucinda crabtreeExchange commissionSa noonan communicationsGlobenewswire incMartin pulPrivate securities litigation reform actAnnual reportBusiness strategyநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்சுசானா நண்பன்ஜூலியா வில்சன்